Table 2.
Intraoperative and postoperative characteristics of secondary cytoreductive surgery for recurrent disease (N = 61)
| Variable | |
|---|---|
| DOD of recurrence to SCS (days) | 26 (0–155) |
| Total Operative Time (min) | 145 (11–405) |
| Estimated Blood Loss (mL)* | 75 (5–1800) |
| Residual Disease | |
| CGR | 46 (75.4) |
| Non-CGR | 15 (24.6) |
| Complication | |
| No | 51 (85) |
| Yes | 9 (15) |
| Complication Grade | |
| 1 | 3 (4.9) |
| 2 | 4 (6.6) |
| 3 | 2 (3.3) |
| Length of stay (days)** | 1 (0–13) |
| Adjuvant therapy | |
| None | 7 (11.5) |
| Chemo | 26 (42.6) |
| RT | 7 (11.5) |
| Chemo-RT | 12 (19.7) |
| Hormone | 9 (14.8) |
Values are presented as numbers (%) or median (range)
DOD, Date of diagnosis of recurrence; SCS, secondary cytoreductive surgery; CGR, complete gross resection; Chemo, chemotherapy; RT, radiation therapy
*
One data point not available
**
Three data points not available